These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31093272)

  • 21. Epigenetic Mechanisms of Aluminum-Induced Neurotoxicity and Alzheimer's Disease: A Focus on Non-Coding RNAs.
    Aschner M; Skalny AV; Santamaria A; Rocha JBT; Mansouri B; Tizabi Y; Madeddu R; Lu R; Lee E; Tinkov AA
    Neurochem Res; 2024 Nov; 49(11):2988-3005. PubMed ID: 39060769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetically regulated microRNAs in Alzheimer's disease.
    Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
    Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's Disease and ncRNAs.
    Maoz R; Garfinkel BP; Soreq H
    Adv Exp Med Biol; 2017; 978():337-361. PubMed ID: 28523555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FRMD4A-cytohesin signaling modulates the cellular release of tau.
    Yan X; Nykänen NP; Brunello CA; Haapasalo A; Hiltunen M; Uronen RL; Huttunen HJ
    J Cell Sci; 2016 May; 129(10):2003-15. PubMed ID: 27044754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
    Kovacech B; Novak M
    Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease.
    Ma X; Liu L; Meng J
    Neurosci Lett; 2017 Nov; 661():57-62. PubMed ID: 28947385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.
    Wang J; Yu JT; Tan MS; Jiang T; Tan L
    Ageing Res Rev; 2013 Sep; 12(4):1024-41. PubMed ID: 23688931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors.
    Sharma VK; Mehta V; Singh TG
    Curr Neuropharmacol; 2020; 18(8):740-753. PubMed ID: 31989902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic drugs in Alzheimer's disease.
    Cuadrado-Tejedor M; Oyarzabal J; Lucas MP; Franco R; García-Osta A
    Biomol Concepts; 2013 Oct; 4(5):433-45. PubMed ID: 25436752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?
    Millan MJ
    Dialogues Clin Neurosci; 2014 Sep; 16(3):373-93. PubMed ID: 25364287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's Disease and Histone Code Alterations.
    Narayan P; Dragunow M
    Adv Exp Med Biol; 2017; 978():321-336. PubMed ID: 28523554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurogenesis-based epigenetic therapeutics for Alzheimer's disease (Review).
    Li X; Bao X; Wang R
    Mol Med Rep; 2016 Aug; 14(2):1043-53. PubMed ID: 27314984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRTC1 gene is differentially methylated in the human hippocampus in Alzheimer's disease.
    Mendioroz M; Celarain N; Altuna M; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Rubio I; Larumbe R; Erro ME; Méndez I; Echávarri C
    Alzheimers Res Ther; 2016 Apr; 8(1):15. PubMed ID: 27094739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetics in Alzheimer's Disease: Perspective of DNA Methylation.
    Qazi TJ; Quan Z; Mir A; Qing H
    Mol Neurobiol; 2018 Feb; 55(2):1026-1044. PubMed ID: 28092081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross Talk Between Aluminum and Genetic Susceptibility and Epigenetic Modification in Alzheimer's Disease.
    Liang R
    Adv Exp Med Biol; 2018; 1091():173-191. PubMed ID: 30315455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.